MoneyWorks4Me

Biogen Pharmachem - Quaterly Results

05 Feb 2025 Evaluate
A minor change in the total revenue was seen in the December 2024 quarter. The total revenue for the quarter stood at Rs. 0.00 millions against Rs. 0.00 millions during year ago period.The Net Loss for the quarter ended December 2024 is Rs. -3.14 millions as compared to Net Profit of Rs. 0.62 millions of corresponding quarter ended December 2023Operating profit Margin for the quarter ended December 2024 slipped to -3.14% as compared to 0.62% of corresponding quarter ended December 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 0.00 0.00 0.00 -0.91 7.53 -112.08 23.82 9.13 160.90
Other Income 2.28 0.92 147.83 -4.22 8.49 -149.71 0.00 0.00 0.00
PBIDT -3.14 0.62 -606.45 -14.69 11.89 -223.55 19.31 4.56 323.46
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -3.14 0.62 -606.45 -14.69 11.89 -223.55 19.31 4.56 323.46
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT -3.14 0.62 -606.45 -14.69 11.89 -223.55 19.31 4.56 323.46
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -3.14 0.62 -606.45 -14.69 11.89 -223.55 19.31 4.56 323.46
Equity 652.60 652.60 0.00 652.60 652.60 0.00 652.60 652.60 0.00
PBIDTM(%) 0.00 0.00 0.00 1614.29 157.90 922.34 81.07 49.95 62.31
Peers
Company Name CMP
Redington 392.20
Amrapali Industries 37.05
Adani Enterprises 3100.00
Rashi Peripheral 805.00
PDS 348.90
View more..